Kieger Sustainable Healthcare Fund Class A USD Accumulating

Reference Data

ISIN LU0996778642
Valor Number 58920661
Bloomberg Global ID
Fund Name Kieger Sustainable Healthcare Fund Class A USD Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager.
Peculiarities

Fund Prices

Current Price * 224.16 USD 12.12.2025
Previous Price * 224.24 USD 11.12.2025
52 Week High * 229.00 USD 26.11.2025
52 Week Low * 196.79 USD 07.08.2025
NAV * 224.16 USD 12.12.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 233,684,887
Unit/Share Assets *** 2,785,920
Trading Information SIX

Performance

YTD Performance +8.03% 31.12.2024
12.12.2025
YTD Performance (in CHF) -5.28% 31.12.2024
12.12.2025
1 month -0.37% 12.11.2025
12.12.2025
3 months +6.45% 12.09.2025
12.12.2025
6 months +4.91% 12.06.2025
12.12.2025
1 year +3.87% 12.12.2024
12.12.2025
2 years +12.36% 12.12.2023
12.12.2025
3 years +13.58% 12.12.2022
12.12.2025
5 years +32.87% 14.12.2020
12.12.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 6.36%
UnitedHealth Group Inc 5.85%
Abbott Laboratories 5.75%
AstraZeneca PLC 5.68%
Novartis AG Registered Shares 5.51%
Roche Holding AG 5.40%
Boston Scientific Corp 4.02%
Vertex Pharmaceuticals Inc 4.00%
Novo Nordisk AS Class B 3.53%
Danaher Corp 3.44%
Last data update 30.09.2025

Cost / Risk

TER *** 0.99%
TER date *** 30.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges *** 1.26%
SRRI ***
SRRI date *** 30.11.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)